The Global NASH Council in the News

MASH is rapidly emerging as one of the most common causes of chronic liver disease worldwide, yet its economic impact has often been underestimated. The Global NASH/MASH Council (GNC) recently conducted an in-depth analysis of the future burden of MASH across nine countries, including the U.S., Germany, France, UK, Italy, Spain, Japan, Brazil, and Saudi...Continue reading→

Dear Colleagues, We would like to invite you to save the date for the International Paris Liver Meeting 2026, a three-day program taking place January 19–21, 2026, covering the latest topics in hepatology, including steatotic liver disease (MASLD, MetALD, ALD), cholestatic liver diseases, viral hepatitis, hepatocellular carcinoma (HCC), and complications of cirrhosis. Join the international...Continue reading→

The Global NASH/MASH Council (GNC) held a highly successful meeting during the annual ALEH Congress in Lima, Peru. Experts from across Latin America discussed key topics related to MASLD in the region, along with potential collaborative projects with GNC. The session was highly interactive and productive. GNC looks forward to strengthening its partnership with ALEH...Continue reading→

This month’s cover of the prestigious journal Gastroenterology features a landmark study by the Global NASH/MASH Council (GNC), which developed global consensus recommendations on the burden, risk stratification, and treatment of MASLD/MASH. By systematically reviewing 61 guidance documents worldwide, the study identified 46 areas of discordance that may create uncertainty for clinicians. Through a four-round...Continue reading→

The prevalence of MASLD/MASH is rising globally, highlighting the urgent need for public health policies that emphasize both prevention and personalized care. MASLD/MASH carries significant clinical, humanistic, and economic burdens worldwide. Primary prevention strategies should prioritize lifestyle interventions guided by a social nutrition agenda, alongside public health initiatives to increase awareness among healthcare practitioners and...Continue reading→

The GNC and GLC extend their heartfelt appreciation to Diane Langenbacher and Nikos Dedes for their outstanding leadership as co-chairs of the Patient Advocacy Committee over the past several years. Their dedication has been instrumental in ensuring that the patient voice remains central to all our initiatives, and we are deeply grateful for their contributions....Continue reading→

This year’s annual ALEH meeting in Lima, Peru features a highly scientific and exciting program. The Global NASH/MASH Council (GNC) and Global Liver Council (GLC) are proud to partner with ALEH to address key topics related to MASLD in Latin America. The GNC/GLC session is scheduled for September 30, 2025, from 15:00 to 17:30.Continue reading→

The global burden of MASLD and MASH is particularly high in the Middle East and North Africa. A recent study published in Liver International by the Global NASH/MASH Council (GNC) provides updated estimates of this regional burden.

People with metabolic dysfunction-associated fatty liver disease (MASLD) benefit from physical activity. But incorporating regular physical activity into the daily routines of patients with MASLD can be challenging due to time limitations and accessibility issues. These challenges are further compounded by the fatigue associated with MASLD. To support individuals with MASLD in initiating and maintaining...Continue reading→

Members of the Global NASH/MASH Council (GNC) are helping reframe Steatotic Liver Disease as a dynamic and evolving spectrum. In a recently published letter, Drs. Zobair M. Younossi, Shira Zelber-Sagi and Aleksander Krag share their expert insights on the future of this significant liver disease. Their perspective highlights the urgent need for a unified approach...Continue reading→